We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
WINDLAS.NSE

Price
967.05
Stock movement up
+74.75 (8.38%)
Company name
Windlas Biotech Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
20.21B
Ent value
22.96B
Price/Sales
2.91
Price/Book
4.29
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
33.01
Forward P/E
-
PEG
-
EPS growth
-0.91%
1 year return
78.65%
3 year return
64.08%
5 year return
-
10 year return
-
Last updated: 2025-04-15

DIVIDENDS

WINDLAS.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E33.01
Price to OCF298.19
Price to FCF298.19
Price to EBITDA86.00
EV to EBITDA97.72

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.91
Price to Book4.29
EV to Sales3.30

FINANCIALS

Per share

Loading...
Per share data
Current share count20.90M
EPS (TTM)29.05
FCF per share (TTM)3.22

Income statement

Loading...
Income statement data
Revenue (TTM)6.96B
Gross profit (TTM)2.01B
Operating income (TTM)532.51M
Net income (TTM)612.28M
EPS (TTM)29.05
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)28.83%
Operating margin (TTM)7.65%
Profit margin (TTM)8.80%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash3.86M
Net receivables0.00
Total current assets5.17B
Goodwill0.00
Intangible assets48.62M
Property, plant and equipment0.00
Total assets7.47B
Accounts payable1.88B
Short/Current long term debt189.53M
Total current liabilities2.71B
Total liabilities2.76B
Shareholder's equity4.71B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)67.78M
Capital expenditures (TTM)0.00
Free cash flow (TTM)67.78M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity12.99%
Return on Assets8.20%
Return on Invested Capital12.54%
Cash Return on Invested Capital1.39%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open926.30
Daily high980.00
Daily low920.05
Daily Volume58K
All-time high1144.25
1y analyst estimate-
Beta0.37
EPS (TTM)29.05
Dividend per share-
Ex-div date17 Sep 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
WINDLAS.NSES&P500
Current price drop from All-time high-15.49%-12.89%
Highest price drop-48.94%-56.47%
Date of highest drop20 Jun 20229 Mar 2009
Avg drop from high-21.97%-11.07%
Avg time to new high20 days12 days
Max time to new high554 days1805 days
COMPANY DETAILS
WINDLAS.NSE (Windlas Biotech Limited) company logo
Marketcap
20.21B
Marketcap category
Large-cap
Description
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.
Employees
1154
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found